Co-Authors
This is a "connection" page, showing publications co-authored by Eugenia Quiros-Roldan and Carlo Torti.
Connection Strength
0.251
-
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort. BMC Infect Dis. 2017 03 15; 17(1):212.
Score: 0.177
-
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Medicine (Baltimore). 2016 Jul; 95(29):e4091.
Score: 0.042
-
Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy. New Microbiol. 2012 Apr; 35(2):227-31.
Score: 0.031